US Stock MarketDetailed Quotes

Palvella Therapeutics (PVLA)

Watchlist
  • 130.010
  • +5.830+4.69%
Close Apr 17 16:00 ET
  • 130.010
  • 0.0000.00%
Post 16:40 ET
1.86BMarket Cap-35.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Palvella Therapeutics (PVLA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-130.68%-25.01M
8.66%-4.93M
-187.31%-7.88M
-238.99%-5.43M
-514.16%-6.77M
20.89%-10.84M
-5.39M
-2.74M
-1.6M
72.13%-1.1M
Net income from continuing operations
-139.27%-41.72M
-221.79%-12.71M
-67.45%-11.35M
-127.01%-9.47M
-222.75%-8.19M
-193.27%-17.43M
---3.95M
---6.78M
---4.17M
62.22%-2.54M
Operating gains losses
-76.56%612K
-95.51%99K
326.67%320K
-56.46%118K
29.31%75K
638.35%2.61M
--2.21M
--75K
--271K
-31.76%58K
Other non cash items
75.73%5.88M
594.78%1.8M
-17.26%1.51M
25.37%1.35M
50.93%1.22M
111.40%3.35M
---364K
--1.83M
--1.08M
-68.79%805K
Change In working capital
2,077.20%3.82M
207.06%3.8M
-107.91%-153K
13.09%1.13M
-327.53%-967K
93.87%-193K
---3.55M
--1.93M
--1M
1,004.26%425K
-Change in receivables
225.99%2.49M
207.89%2.13M
--0
--0
--358K
---1.98M
---1.98M
--0
--0
--0
-Change in prepaid assets
190.75%1.36M
117.62%222K
235.82%182K
406.13%499K
753.70%461K
-650.55%-1.5M
---1.26M
---134K
---163K
-46.53%54K
-Change in payables and accrued expense
-101.22%-40K
559.68%1.45M
-116.20%-335K
-45.62%633K
-581.40%-1.79M
196.08%3.29M
---315K
--2.07M
--1.16M
350.68%371K
Cash from discontinued investing activities
Operating cash flow
-130.68%-25.01M
8.66%-4.93M
-187.31%-7.88M
-238.99%-5.43M
-514.16%-6.77M
20.89%-10.84M
---5.39M
---2.74M
---1.6M
72.13%-1.1M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-100.76%-660K
-100.07%-49K
-89.97%242K
-96.47%349K
-1.2M
1,641.78%87.09M
74.79M
2.41M
9.89M
0
Net issuance payments of debt
--0
--0
--0
----
----
--78.43M
--66M
--2.43M
----
----
Proceeds from stock option exercised by employees
--763K
--105K
--242K
--349K
--67K
--0
--0
--0
--0
--0
Net other financing activities
-116.44%-1.42M
-101.75%-154K
--0
--0
---1.27M
73.10%8.66M
--8.78M
---21K
----
----
Cash from discontinued financing activities
Financing cash flow
-100.76%-660K
-100.07%-49K
-89.97%242K
-96.47%349K
---1.2M
1,641.78%87.09M
--74.79M
--2.41M
--9.89M
--0
Net cash flow
Beginning cash position
1,037.44%83.6M
347.43%63.57M
384.51%70.43M
1,110.40%75.63M
1,037.44%83.6M
-54.21%7.35M
--14.21M
--14.54M
--6.25M
-54.21%7.35M
Current changes in cash
-133.66%-25.67M
-107.17%-4.98M
-2,213.94%-7.64M
-161.35%-5.09M
-623.23%-7.97M
976.12%76.25M
--69.39M
---330K
--8.29M
72.13%-1.1M
Effect of exchange rate changes
1,433.33%46K
-20,433.33%-610K
--770K
---108K
---6K
--3K
--3K
--0
--0
--0
End cash Position
-30.65%57.98M
-30.65%57.98M
347.43%63.57M
384.51%70.43M
1,110.40%75.63M
1,037.44%83.6M
--83.6M
--14.21M
--14.54M
-48.36%6.25M
Free cash flow
-130.68%-25.01M
8.66%-4.93M
-187.31%-7.88M
-238.99%-5.43M
-514.16%-6.77M
20.89%-10.84M
---5.39M
---2.74M
---1.6M
72.13%-1.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -130.68%-25.01M8.66%-4.93M-187.31%-7.88M-238.99%-5.43M-514.16%-6.77M20.89%-10.84M-5.39M-2.74M-1.6M72.13%-1.1M
Net income from continuing operations -139.27%-41.72M-221.79%-12.71M-67.45%-11.35M-127.01%-9.47M-222.75%-8.19M-193.27%-17.43M---3.95M---6.78M---4.17M62.22%-2.54M
Operating gains losses -76.56%612K-95.51%99K326.67%320K-56.46%118K29.31%75K638.35%2.61M--2.21M--75K--271K-31.76%58K
Other non cash items 75.73%5.88M594.78%1.8M-17.26%1.51M25.37%1.35M50.93%1.22M111.40%3.35M---364K--1.83M--1.08M-68.79%805K
Change In working capital 2,077.20%3.82M207.06%3.8M-107.91%-153K13.09%1.13M-327.53%-967K93.87%-193K---3.55M--1.93M--1M1,004.26%425K
-Change in receivables 225.99%2.49M207.89%2.13M--0--0--358K---1.98M---1.98M--0--0--0
-Change in prepaid assets 190.75%1.36M117.62%222K235.82%182K406.13%499K753.70%461K-650.55%-1.5M---1.26M---134K---163K-46.53%54K
-Change in payables and accrued expense -101.22%-40K559.68%1.45M-116.20%-335K-45.62%633K-581.40%-1.79M196.08%3.29M---315K--2.07M--1.16M350.68%371K
Cash from discontinued investing activities
Operating cash flow -130.68%-25.01M8.66%-4.93M-187.31%-7.88M-238.99%-5.43M-514.16%-6.77M20.89%-10.84M---5.39M---2.74M---1.6M72.13%-1.1M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -100.76%-660K-100.07%-49K-89.97%242K-96.47%349K-1.2M1,641.78%87.09M74.79M2.41M9.89M0
Net issuance payments of debt --0--0--0----------78.43M--66M--2.43M--------
Proceeds from stock option exercised by employees --763K--105K--242K--349K--67K--0--0--0--0--0
Net other financing activities -116.44%-1.42M-101.75%-154K--0--0---1.27M73.10%8.66M--8.78M---21K--------
Cash from discontinued financing activities
Financing cash flow -100.76%-660K-100.07%-49K-89.97%242K-96.47%349K---1.2M1,641.78%87.09M--74.79M--2.41M--9.89M--0
Net cash flow
Beginning cash position 1,037.44%83.6M347.43%63.57M384.51%70.43M1,110.40%75.63M1,037.44%83.6M-54.21%7.35M--14.21M--14.54M--6.25M-54.21%7.35M
Current changes in cash -133.66%-25.67M-107.17%-4.98M-2,213.94%-7.64M-161.35%-5.09M-623.23%-7.97M976.12%76.25M--69.39M---330K--8.29M72.13%-1.1M
Effect of exchange rate changes 1,433.33%46K-20,433.33%-610K--770K---108K---6K--3K--3K--0--0--0
End cash Position -30.65%57.98M-30.65%57.98M347.43%63.57M384.51%70.43M1,110.40%75.63M1,037.44%83.6M--83.6M--14.21M--14.54M-48.36%6.25M
Free cash flow -130.68%-25.01M8.66%-4.93M-187.31%-7.88M-238.99%-5.43M-514.16%-6.77M20.89%-10.84M---5.39M---2.74M---1.6M72.13%-1.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -